BG
HCM icon

Bellevue Group’s HUTCHMED HCM Stock Holding History

Bellevue Group’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,015
Closed -$469K – 167
2024
Q3 		$469K Sell
24,015
-1,125,142
-98% -$20.3M 0.01% 130
2024
Q2 		$19.7M Sell
1,149,157
-5,475
-0.5% -$101K 0.32% 74
2024
Q1 		$19.4M Buy
1,154,632
+23,521
+2% +$357K 0.3% 78
2023
Q4 		$20.4M Sell
1,131,111
-671,852
-37% -$12.2M 0.31% 74
2023
Q3 		$30.6M Sell
1,802,963
-2,620
-0.1% -$37.5K 0.49% 57
2023
Q2 		$21.7M Sell
1,805,583
-21,387
-1% -$292K 0.31% 72
2023
Q1 		$23.8M Buy
1,826,970
+46,826
+3% +$767K 0.35% 72
2022
Q4 		$28.4M Buy
1,780,144
+22,069
+1% +$241K 0.38% 72
2022
Q3 		$15.9M Buy
1,758,075
+1,768
+0.1% +$22.2K 0.23% 92
2022
Q2 		$21.4M Buy
1,756,307
+5,617
+0.3% +$71.5K 0.3% 84
2022
Q1 		$33.1M Buy
1,750,690
+673,820
+63% +$17.2M 0.38% 79
2021
Q4 		$37.8M Buy
1,076,870
+70,723
+7% +$2.3M 0.39% 77
2021
Q3 		$36.8M Buy
1,006,147
+141,387
+16% +$5.56M 0.37% 82
2021
Q2 		$34M Sell
864,760
-110,728
-11% -$3.2M 0.33% 89
2021
Q1 		$27.6M Buy
975,488
+27,814
+3% +$887K 0.29% 92
2020
Q4 		$30.3M Hold
947,674
– – 0.35% 79
2020
Q3 		$30.6M Hold
947,674
– – 0.42% 66
2020
Q2 		$26.1M Buy
947,674
+95,680
+11% +$2.08M 0.37% 68
2020
Q1 		$15.2M Buy
851,994
+34,177
+4% +$824K 0.29% 69
2019
Q4 		$20.5M Buy
817,817
+29,619
+4% +$648K 0.33% 59
2019
Q3 		$13.8M Buy
788,198
+189,888
+32% +$3.95M 0.26% 72
2019
Q2 		$13.2M Hold
598,310
– – 0.22% 73
2019
Q1 		$18.3M Buy
598,310
+158,141
+36% +$3.94M 1.01% 30
2018
Q4 		$10.2M Buy
440,169
+40,140
+10% +$1.25M 0.67% 44
2018
Q3 		$12.9M Buy
400,029
+67,493
+20% +$2.06M 0.82% 43
2018
Q2 		$10M Buy
332,536
+30,116
+10% +$956K 0.85% 45
2018
Q1 		$8.94M Buy
302,420
+168,570
+126% +$5.99M 0.89% 44
2017
Q4 		$5.26M Buy
133,850
+69,277
+107% +$2.21M 0.55% 47
2017
Q3 		$1.75M Buy
64,573
+35,331
+121% +$867K 0.18% 86
2017
Q2 		$682K Buy
+29,242
New +$600K 0.08% 120

Other funds holding HCM

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
CFM
Catalyst Funds Management Sydney NSW, Australia $591M AUM 71.09% 1-Year Est. Return

Bellevue Group's HCM Position: Q4 2024 in Review

Bellevue Group sold out of HUTCHMED (HCM) in Q4 2024, closing a stake of 24,015 shares — an estimated $469K sold.

Bellevue Group first reported a position in HCM in Q2 2017 and held it in 30 quarters. The position peaked at $37.8M in Q4 2021. 69 funds tracked by Wall St. Rank hold HCM as of Q4 2024.

  • Bellevue Group reported no remaining HUTCHMED position as of Q4 2024 after selling out during the quarter.
  • Bellevue Group sold 24,015 HUTCHMED shares in Q4 2024, an estimated $469K.
  • Bellevue Group first reported a position in HUTCHMED in Q2 2017 and held it in 30 quarters.
  • Bellevue Group's HUTCHMED position peaked at $37.8M in Q4 2021.
  • 69 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2024.

Based on Bellevue Group's 13F filing for Q4 2024, filed 14 Feb 2025.